Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Sequire Spotlight Presents Guerilla RF (GUER): The Experts in Cellular and Wifi Semiconductors

VP of Investor Relations, Sam Funchess, discusses Guerilla RF’s ability to overcome typical challenges in the semiconductor industry, as well as their outstanding supply chain track record.

semiconductors
June 17, 2022

Related Videos

Related Posts

Related Videos

Sequire Spotlight Presents: Ideal Power (IPWR) – Power Semiconductors November 25, 2024
Sequire Spotlight Presents: Spectra7 (SPVNF) – Semiconductors Enabling Higher Performance November 20, 2024
Sequire Spotlight Presents ICZOOM Group Inc. (IZM): Connecting Businesses for Seamless Growth October 28, 2023
Sequire Spotlight Presents GUERRILLA RF (GUER): RF Semiconductors for Industries & Commerce June 30, 2023
Sequire Spotlight Presents SmartKem, Inc. (SMTK): Pioneer In Design, Synthesis & Supply Of High-Performance Semiconductor & OTFT Technology February 08, 2023
Sequire Spotlight Presents Aehr Test Systems (AEHR): Building Semiconductor Test Systems November 09, 2022
Sequire Spotlight Presents Guerrilla RF (GUER): A Radio Frequency Semi-Conductor Company November 08, 2022
Sequire Spotlight Presents Guerrilla RF (GUER): Making Waves with Radio Frequency Semiconductors September 19, 2022
Sequire Spotlight Presents SmartKem, Inc. (SMTK): A New Class of Semiconductor Material August 26, 2022
Sequire Spotlight Presents Kingsway Financial Services Inc (KFS): Leveraging the Search Fund Model July 07, 2023

Related Post

Reshaping the World of Electronics

January 18, 2023
Acurx Pharmaceuticals to Join the Russell Microcap Index®

September 2, 2021
22nd Century Announces $3.0 Million Registered Direct Offering Priced Above Market

July 6, 2023
Oncolytics Biotech® Provides Enrollment Update on Multi-Indication Phase 1/2 Gastrointestinal Cancer Trial at the 2022 American Society of Clinical Oncology Gastrointestinal Cancers Symposium

January 20, 2022

Microcaps.com is a trademark of SRAX, Inc.

Privacy Policy
Cookie Policy
Contact Us

About SRAX
About Sequire

We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.